Saladax Biomedical, Inc.
PrivateLast Round
VC Round
May 24, 2023
Est. Valuation
$89.93M
Total Funding Raised
$30.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Saladax Biomedical, Inc. operates in Healthcare & Life Sciences and is based in Bethlehem, Pennsylvania. Its latest recorded funding round was a VC Round in May 2023.
Saladax Biomedical, Inc. is a biotechnology company that develops and manufactures therapeutic drug monitoring (TDM) assays for essential medications prescribed by psychiatrists and oncologists.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saladax Biomedical, Inc. Comparables
Compare Saladax Biomedical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ARK Diagnostics, Inc. | 81% | |
| Thermo Fisher Scientific Inc. | 73% | |
| Axithra | 68% |
For institutional investors. Book with your work email.
Saladax Biomedical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 24, 2023 | ||||
| Series D | Mar 4, 2013 | ||||
| Series C | Mar 5, 2010 | ||||
| VC Round | Apr 17, 2009 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Saladax Biomedical, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | VC Round, Series C |
| Life Sciences Greenhouse Investments | VC Round, Series C |
| Excel Venture Management | Series C |
| Delaware Crossing Investor Group | VC Round |
| Golden Seeds | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 77% MoM.
- May 3, 2025
Monthly visitors increased 51% MoM.
For institutional investors. Book with your work email.
Saladax Biomedical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Saladax Biomedical, Inc.'s valuation, stock price, and market status.
Is Saladax Biomedical, Inc. a public or private company?
Saladax Biomedical, Inc. is a private company.
What is the current stock price of Saladax Biomedical, Inc.?
Saladax Biomedical, Inc. is a private company, so its shares have no public market price. Caplight tracks Saladax Biomedical, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Saladax Biomedical, Inc. worth (valuation)?
Saladax Biomedical, Inc.'s valuation is estimated at $89.9M based on funding round data.
Can I buy Saladax Biomedical, Inc. stock?
Saladax Biomedical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Saladax Biomedical, Inc.'s last funding round?
Saladax Biomedical, Inc.'s most recent funding round was VC Round on May 24, 2023.
Who are the main investors in Saladax Biomedical, Inc.?
Key investors in Saladax Biomedical, Inc. include Benjamin Franklin Technology Partners, Excel Venture Management.
Will Saladax Biomedical, Inc. IPO soon?
No public IPO plans have been announced for Saladax Biomedical, Inc..
How can I track Saladax Biomedical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Saladax Biomedical, Inc.'s shares on secondary markets.